Literature DB >> 35035636

Frequently asked questions about naloxone: Part 3.

Ashley Cid1, Alec Patten1, Kelly Grindrod1, Michael A Beazely1.   

Abstract

Entities:  

Year:  2021        PMID： 35035636      PMCID： PMC8756371          DOI： 10.1177/17151635211056571

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  8 in total

1.  ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders.

Authors:  Michael J Moss; Brandon J Warrick; Lewis S Nelson; Charles A McKay; Pierre-André Dubé; Sophie Gosselin; Robert B Palmer; Andrew I Stolbach
Journal:  Clin Toxicol (Phila)       Date:  2017-09-05       Impact factor: 4.467

2.  No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone.

Authors:  Jermaine D Jones; Aimee Campbell; Verena E Metz; Sandra D Comer
Journal:  Addict Behav       Date:  2017-03-09       Impact factor: 3.913

Review 3.  Synthetic Opioids.

Authors:  Patrick M Beardsley; Yan Zhang
Journal:  Handb Exp Pharmacol       Date:  2018

4.  Quality Assessment of Expired Naloxone Products from First-Responders' Supplies.

Authors:  Schuyler Pruyn; Justin Frey; Benjamin Baker; Michael Brodeur; Carla Graichen; Heather Long; Haian Zheng; Michael Winter Dailey
Journal:  Prehosp Emerg Care       Date:  2019-02-04       Impact factor: 3.077

Review 5.  Carfentanil: a narrative review of its pharmacology and public health concerns.

Authors:  Jessica L S Leen; David N Juurlink
Journal:  Can J Anaesth       Date:  2019-01-21       Impact factor: 5.063

6.  The effects of heat and freeze-thaw cycling on naloxone stability.

Authors:  Dulcie Lai; Amy Trinh Pham; Praveen P Nekkar Rao; Michael A Beazely
Journal:  Harm Reduct J       Date:  2019-02-27

7.  Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.

Authors:  Alice Bell; Alex S Bennett; T Stephen Jones; Maya Doe-Simkins; Leslie D Williams
Journal:  Subst Abus       Date:  2018-06-25       Impact factor: 3.716

8.  Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.

Authors:  Andrew McAuley; Janet Bouttell; Lee Barnsdale; Daniel Mackay; Jim Lewsey; Carole Hunter; Mark Robinson
Journal:  Addiction       Date:  2016-11-06       Impact factor: 6.526
  8 in total
  1 in total

1.  Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial.

Authors:  Ashley Cid; Alec Patten; Michael Beazely; Kelly Grindrod; Jennifer Yessis; Feng Chang
Journal:  Pharmacy (Basel)       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.